Hoth Therapeutics, Inc

(NASDAQ:HOTH)

Latest On Hoth Therapeutics, Inc (HOTH):

Date/Time Type Description Signal Details
2023-05-12 10:15 ESTNewsHoth Therapeutics ticks higher after termination of merger with Algorithm SciencesN/A
2023-04-26 18:30 ESTNewsHoth stock falls ~15% on plans to merge with Algorithm SciencesN/A
2023-02-17 03:57 ESTNewsHoth jumps 26% on deal to monitor illegal short sellingN/A
2023-02-08 22:16 ESTNewsHoth stock rises ~20% as Alzheimer's drug shows promise in mice studyN/A
2022-12-30 09:49 ESTNewsHoth Therapeutics falls 38% on $10M private placementN/A
2022-12-30 09:49 ESTNewsTTOO, EDU and TAL among premarket losersN/A
2022-12-29 18:57 ESTNewsHoth Therapeutics surges 35% on FDA nod to begin trial of treatment for skin disorders in cancer patientsN/A
2022-12-02 06:12 ESTNewsHoth Therapeutics seeks FDA nod for treatment of skin disorders in cancer patientsN/A
2022-11-10 01:09 ESTNewsHoth Therapeutics regains compliance with Nasdaq listing rulesN/A
2022-10-31 19:10 ESTNewsHoth posts positive early-stage data for atopic dermatitis therapyN/A
2022-10-24 22:41 ESTNewsHoth Therapeutics falls 13% after the bell on 1-for-25 reverse stock splitN/A
2022-09-20 17:29 ESTNewsHoth Therapeutics partners with Altasciences to manufacture HT-TBI for brain injuryN/A
2022-07-13 02:43 ESTNewsHoth adds 39% as mouse model shows proof-of-concept for Alzheimer’s candidateN/A
2022-06-29 18:00 ESTNewsHoth Therapeutics granted grace days by Nasdaq to regain compliance with bid price ruleN/A
2022-06-09 14:40 ESTNewsHoth extends Washington Uni. Alzheimer's mouse model study with its HT-ALZ therapeuticN/A
2022-04-19 23:37 ESTNewsHoth adds drug/device product HT-TBI to pipeline as potential therapy for brain injuryN/A
2022-04-12 12:40 ESTNewsHoth Therapeutics slides on pricing $7.0M stock offeringN/A
2022-04-11 21:44 ESTNewsHoth Therapeutics surges on preclinical data for cancer therapyN/A
2022-04-11 21:43 ESTNewsHoth Therapeutics slides on public offering of common stockN/A
2022-03-10 17:05 ESTNewsHoth Therapeutics spikes on FDA’s Orphan Drug status for mastocytosis therapyN/A
2022-01-05 22:11 ESTNewsHoth Therapeutics pares gains following Alzheimer's data; shares down 20%N/A
2022-01-04 13:51 ESTNewsHoth highlights promise of Alzheimer’s therapy with data from animal studyN/A
2021-12-09 21:25 ESTNewsWarning: HOTH is at high risk of performing badlyN/A
2021-11-16 21:59 ESTNewsHoth inks research agreement for development of mRNA cancer therapyN/A
2021-10-13 02:01 ESTNewsHoth Therapeutics gets clearance for BioLexa atopic dermatitis study in AustraliaN/A
2021-09-08 09:54 ESTNewsHoth Therapeutics reports positive results from first cohort of BioLexa trialN/A
2021-08-11 22:02 ESTNewsHoth Therapeutics' jumps 9% after mRNA 'Frameshifting' therapy reduces size, spread of cancer cellsN/A
2021-07-21 11:32 ESTNewsHoth Therapeutics pops 4% on positive preclinical results of HT-KIT in mast cell cancersN/A
2021-07-21 11:24 ESTNewsHoth Therapeutics extends agreement for experimental antibioticN/A
2021-07-21 11:17 ESTNewsHoth Therapeutics shares rise on BioLexa atopic dermatitis dataN/A
2021-07-21 11:10 ESTNewsHoth Therapeutics posts confirmatory results from in vivo HT-003 acne studyN/A
2021-05-05 17:30 ESTNewsHoth Therapeutics expands research agreement with VCU for COVID-19 therapeuticN/A
2021-05-03 23:56 ESTNewsHoth Therapeutics shares rise 10% on developmental plans for HT-KIT in multiple orphan diseases and rare cancersN/A
2021-04-22 16:17 ESTNewsHoth Therapeutics' human trial underway evaluating BioLexa for eczemaN/A
2021-04-21 00:52 ESTNewsHoth Therapeutics shares rise on positive data from anti-cancer therapeuticN/A
2021-04-12 21:00 ESTNewsHoth Therapeutics completes HT-001 formulation development for upcoming cancer trialN/A
2021-04-06 22:03 ESTNewsHoth Therapeutics engages worldwide clinical trials for mid-stage HT-001 trialN/A
2021-04-05 09:51 ESTNewsTSLA, NVTA, CHPT and NNOX among premarket gainersN/A
2021-04-05 09:51 ESTNewsHoth issued notice of allowance for biofilms inhibition patent applicationN/A
2021-03-24 19:35 ESTNewsHoth Therapeutics partner discloses positive preclinical results for COVID-19 vaccineN/A
2021-03-24 00:34 ESTNewsHoth Therapeutics (HOTH) shares surge 56% on encouraging HT-002 data in COVID-19N/A
2021-03-18 00:03 ESTNewsHoth inks research deal to test HT-006 with UCRIN/A
2021-03-17 16:45 ESTFinancialsCompany financials have been released.Neutral
2021-03-12 05:00 ESTNewsHoth signs agreement to evaluate platform on ulcerative colitis, Crohn'sN/A
2021-03-09 18:00 ESTNewsHoth Therapeutics trades lower after $15M capital raiseN/A
2021-03-04 03:30 ESTNewsHoth Therapeutics updates on HT-002 in COVID-19 preclinical studyN/A
2021-03-01 18:32 ESTNewsHoth Therapeutics completes site recruitment for atopic dermatitis study cohort 1N/A
2021-02-26 20:29 ESTNewsHoth Therapeutics expands license agreement to include innovative cancer treatmentN/A
2021-02-25 03:39 ESTNewsHoth Therapeutics expands IP portfolio with novel Alzheimer's disease treatmentN/A
2021-02-23 15:31 ESTNewsHoth shares rise on positive pre-IND FDA meeting for HT-001 developmentN/A

About Hoth Therapeutics, Inc (HOTH):

Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. It intends to use the BioLexa Platform to develop two topical cream products that treat eczema and reduces post-procedure infections for patients undergoing aesthetic dermatology procedures. The company has license agreements with the George Washington University; the University of Maryland Baltimore; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; and the University of Cincinnati. It also has a partnership agreement with Zylö Therapeutics Inc. co-develop a new topical treatment for patients with Cutaneous Lupus Erythematosu, a chronic autoimmune disease that affects the skin and is associated with a significant burden on patient quality of life. Hoth Therapeutics has research collaboration agreement with Weill Cornell Medicine to continue the advancement of HT-003 for acne treatment research. Hoth Therapeutics, Inc. was founded in 2017 and is headquartered in New York, New York.

HOTH Quotes by TradingView

See Advanced Chart

General

  • Name Hoth Therapeutics, Inc
  • Symbol HOTH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 2
  • Fiscal Year EndDecember
  • IPO Date2019-02-15
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.hoththerapeutics.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 9.09
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Next Quarter EPS Estimate -$0.08
  • Return on Assets -113%
  • Return on Equity -204%
  • Earnings Per Share -$0.49
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 49.35 million
  • EBITDA -3300285
  • Analyst Target Price $10
  • Book Value Per Share $0.40
View More

Share Statistics

  • Shares Outstanding 22.74 million
  • Shares Float 7.67 million
  • % Held by Insiders 3789%
  • % Held by Institutions 1.56%
  • Shares Short 392794
  • Shares Short Prior Month 387287
  • Short Ratio 0.09
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.22
  • 52 Week High $4.39
  • 52 Week Low $1.56
  • 50 Day Moving Average 2.27
  • 200 Day Moving Average 2.03
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Hoth Therapeutics, Inc (HOTH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Hoth Therapeutics, Inc (HOTH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-08$N/A-$0.06
2020-09-302020-11-10$N/A-$0.16-$0.14-18.52%
2020-06-302020-08-13$N/A-$0.20-$0.14-48.15%
2020-03-312020-05-13$N/A-$0.18-$0.17-7.98%
2019-12-312020-03-02$N/A-$0.41-$0.14-199.93%
2019-09-302019-11-12$N/A-$0.17-$0.10-64.57%
2019-06-302019-08-14$N/A-$0.13-$0.11-18.18%
2019-03-312019-04-01$N/A-$0.12
2018-12-312019-03-31$N/A-$0.06

Hoth Therapeutics, Inc (HOTH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 170557 748929 N/A 687060 1.04 million
Income Before Tax -756787 -2.12 million N/A -1.83 million -3.91 million
Selling General Administrative 538536 1.3 million N/A 980148 2.76 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -802752 -2.17 million N/A -1.82 million -3.92 million
Operating Income -802876 -2.17 million N/A -1.82 million -3.92 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net 46089 49908 N/A -10126 5949
Net Income From Continuing Operations -756787 -2.12 million N/A -1.83 million -3.91 million
Net Income Applicable to Common Shares N/A -2.12 million -2.5 million N/A -3.91 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A 10168 N/A -800000
Change to Liabilities -149722 -218219 N/A 384324 -181953
Total Cash Flow from Investing Activities 671606 -1.7 million N/A -25000 -850000
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 4.23 million N/A 1.61 million
Change to Operating Activities -22826 -191 N/A 3824 -12576
Change in Cash N/A N/A 2.66 million -1.52 million -877761
Total Cash from Operating Activities -1.5 million -2.4 million -1.58 million -1.5 million -1.64 million
Depreciation N/A N/A 305 309 308
Other Cash Flow from Investing Activities -50000 N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 793533 318211 N/A 2.02 million 252363
Capital Expenditures N/A N/A 39832 N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 597149 572871 N/A 523312 440121
Total Stockholder Equity 4.65 million 5.38 million N/A 4.82 million 2.4 million
Other Current Liabilities N/A N/A N/A N/A N/A
Total Assets 5.24 million 5.95 million N/A 5.35 million 2.84 million
Common Stock N/A 1343 1343 N/A 1012
Other Current Assets N/A N/A N/A N/A 30484
Retained Earnings -19.41 million -18.66 million -16.54 million -14.04 million -12.22 million
Other Liabilities N/A 285000 235000 N/A N/A
Other Assets N/A 50000 N/A N/A 200000
Cash 2.63 million 4.12 million N/A 4.35 million 1.69 million
Total Current Liabilities 312149 287871 N/A 523312 440121
Other Stockholder Equity N/A -3491 -662 N/A N/A
Property, Plant & Equipment N/A 124 433 N/A 1043
Total Current Assets 4.78 million 5.49 million N/A 4.9 million 2.64 million
Long Term Investments 410000 410000 N/A 250000 N/A
Net Tangible Assets N/A 5.38 million 6.84 million N/A 2.4 million
Short Term Investments 2.06 million 1.29 million N/A 490992 803664
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 129469 22919 N/A 515412 403885

Hoth Therapeutics, Inc (HOTH) Chart:

Hoth Therapeutics, Inc (HOTH) News:

Below you will find a list of latest news for Hoth Therapeutics, Inc (HOTH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Hoth Therapeutics, Inc (HOTH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest HOTH Trades:

Date Shares Price
Jun 13, 2022 5:57 PM EST100$0.4087
Jun 13, 2022 7:59 PM EST100$0.4084
Jun 13, 2022 7:59 PM EST58$0.4084
Jun 13, 2022 7:59 PM EST42$0.4084
Jun 13, 2022 7:59 PM EST100$0.4084

Hoth Therapeutics, Inc (HOTH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020016495/0001213900-20-016495-index.htm
2018-07-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000018022089/0000000000-18-022089-index.htm
2018-09-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000018027308/0000000000-18-027308-index.htm
2018-10-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000018033579/0000000000-18-033579-index.htm
2019-02-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000019000617/0000000000-19-000617-index.htm
2019-02-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000019001057/0000000000-19-001057-index.htm
2019-09-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000019013327/0000000000-19-013327-index.htm
2019-10-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000019014354/0000000000-19-014354-index.htm
2020-03-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000020002104/0000000000-20-002104-index.htm
2020-04-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711786/000000000020003134/0000000000-20-003134-index.htm
2020-02-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711786/000110465920026927/0001104659-20-026927-index.htm
2020-02-285Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000110465920026941/0001104659-20-026941-index.htm
2017-07-14DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390017007563/0001213900-17-007563-index.htm
2017-11-07DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390017011517/0001213900-17-011517-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390019002926/0001213900-19-002926-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003520/0001213900-19-003520-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003524/0001213900-19-003524-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003526/0001213900-19-003526-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003528/0001213900-19-003528-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003530/0001213900-19-003530-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003742/0001213900-19-003742-index.htm
2019-03-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003746/0001213900-19-003746-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019003749/0001213900-19-003749-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1711786/000121390019005307/0001213900-19-005307-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390019007320/0001213900-19-007320-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711786/000121390019008830/0001213900-19-008830-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711786/000121390019015804/0001213900-19-015804-index.htm
2019-08-21DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019016442/0001213900-19-016442-index.htm
2019-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390019016473/0001213900-19-016473-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390019016599/0001213900-19-016599-index.htm
2019-08-30S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000121390019017016/0001213900-19-017016-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390019017375/0001213900-19-017375-index.htm
2019-09-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000121390019017735/0001213900-19-017735-index.htm
2019-09-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000121390019017814/0001213900-19-017814-index.htm
2019-09-16424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711786/000121390019018153/0001213900-19-018153-index.htm
2019-09-26S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000121390019019010/0001213900-19-019010-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390019020744/0001213900-19-020744-index.htm
2019-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000121390019020932/0001213900-19-020932-index.htm
2019-10-23S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000121390019020936/0001213900-19-020936-index.htm
2019-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000121390019020939/0001213900-19-020939-index.htm
2019-10-25424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711786/000121390019021178/0001213900-19-021178-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711786/000121390019022971/0001213900-19-022971-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019026996/0001213900-19-026996-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019026997/0001213900-19-026997-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019026999/0001213900-19-026999-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019027000/0001213900-19-027000-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390019027001/0001213900-19-027001-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020003890/0001213900-20-003890-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020003951/0001213900-20-003951-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1711786/000121390020005186/0001213900-20-005186-index.htm
2020-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020005405/0001213900-20-005405-index.htm
2020-03-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000121390020005411/0001213900-20-005411-index.htm
2020-03-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020005418/0001213900-20-005418-index.htm
2020-03-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000121390020005745/0001213900-20-005745-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020007153/0001213900-20-007153-index.htm
2020-03-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711786/000121390020007155/0001213900-20-007155-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020007353/0001213900-20-007353-index.htm
2020-03-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711786/000121390020007361/0001213900-20-007361-index.htm
2020-04-03S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000121390020008546/0001213900-20-008546-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020009344/0001213900-20-009344-index.htm
2020-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020009449/0001213900-20-009449-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020009452/0001213900-20-009452-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020009453/0001213900-20-009453-index.htm
2020-05-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000121390020011025/0001213900-20-011025-index.htm
2020-05-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000121390020011027/0001213900-20-011027-index.htm
2020-05-07424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711786/000121390020011222/0001213900-20-011222-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711786/000121390020012014/0001213900-20-012014-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020012878/0001213900-20-012878-index.htm
2020-05-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020012934/0001213900-20-012934-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020013226/0001213900-20-013226-index.htm
2020-05-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711786/000121390020013240/0001213900-20-013240-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020013321/0001213900-20-013321-index.htm
2020-05-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711786/000121390020013343/0001213900-20-013343-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020013642/0001213900-20-013642-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020013694/0001213900-20-013694-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020016495/0001213900-20-016495-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020016921/0001213900-20-016921-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020017874/0001213900-20-017874-index.htm
2020-07-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020018167/0001213900-20-018167-index.htm
2020-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020018407/0001213900-20-018407-index.htm
2020-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020018408/0001213900-20-018408-index.htm
2020-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020018409/0001213900-20-018409-index.htm
2020-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020018410/0001213900-20-018410-index.htm
2020-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020018411/0001213900-20-018411-index.htm
2020-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020018414/0001213900-20-018414-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020020379/0001213900-20-020379-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020021059/0001213900-20-021059-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711786/000121390020021878/0001213900-20-021878-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020022690/0001213900-20-022690-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020024583/0001213900-20-024583-index.htm
2020-09-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000121390020025860/0001213900-20-025860-index.htm
2020-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020026170/0001213900-20-026170-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711786/000121390020027547/0001213900-20-027547-index.htm
2019-02-07CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1711786/000135445719000061/0001354457-19-000061-index.htm
2018-06-21DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1711786/000161577418005553/0001615774-18-005553-index.htm
2018-08-14DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1711786/000161577418007947/0001615774-18-007947-index.htm
2018-08-13DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1711786/000161577418007949/0001615774-18-007949-index.htm
2018-10-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577418010669/0001615774-18-010669-index.htm
2018-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577418010671/0001615774-18-010671-index.htm
2018-12-14S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577418014482/0001615774-18-014482-index.htm
2018-12-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577418014483/0001615774-18-014483-index.htm
2019-01-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577419000531/0001615774-19-000531-index.htm
2019-02-01S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577419001684/0001615774-19-001684-index.htm
2019-02-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419001685/0001615774-19-001685-index.htm
2019-02-04S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577419001852/0001615774-19-001852-index.htm
2019-02-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577419001957/0001615774-19-001957-index.htm
2019-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419001958/0001615774-19-001958-index.htm
2019-02-068-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1711786/000161577419001991/0001615774-19-001991-index.htm
2019-02-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577419002001/0001615774-19-002001-index.htm
2019-02-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002003/0001615774-19-002003-index.htm
2019-02-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002005/0001615774-19-002005-index.htm
2019-02-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711786/000161577419002253/0001615774-19-002253-index.htm
2019-02-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002257/0001615774-19-002257-index.htm
2019-02-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002259/0001615774-19-002259-index.htm
2019-02-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002261/0001615774-19-002261-index.htm
2019-02-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002263/0001615774-19-002263-index.htm
2019-02-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002591/0001615774-19-002591-index.htm
2019-02-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002593/0001615774-19-002593-index.htm
2019-02-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002595/0001615774-19-002595-index.htm
2019-02-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002597/0001615774-19-002597-index.htm
2019-02-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711786/000161577419002599/0001615774-19-002599-index.htm
2019-02-15424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1711786/000161577419002658/0001615774-19-002658-index.htm
2019-02-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711786/999999999519000250/9999999995-19-000250-index.htm
2019-09-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711786/999999999519002094/9999999995-19-002094-index.htm
2019-10-25EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711786/999999999519002397/9999999995-19-002397-index.htm
2020-03-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711786/999999999520000555/9999999995-20-000555-index.htm
2020-05-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711786/999999999520001061/9999999995-20-001061-index.htm
2019-02-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1711786/999999999719000376/9999999997-19-000376-index.htm

Hoth Therapeutics, Inc (HOTH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hoth Therapeutics, Inc (HOTH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3789%
Institutional Ownership: 156%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-26Anthony Hayes10% Share HolderSell400,000.001.25500,000.001,130,674.00https://www.sec.gov/Archives/edgar/data/1711786/000121390020013694/0001213900-20-013694-index.htm
2020-04-15Graig SpringerDirectorBuy3,333.003,333.00https://www.sec.gov/Archives/edgar/data/1711786/000121390020009344/0001213900-20-009344-index.htm
2020-04-15Wayne LinsleyDirectorBuy3,333.003,333.00https://www.sec.gov/Archives/edgar/data/1711786/000121390020009453/0001213900-20-009453-index.htm